ALX ONCOLOGY HOLDINGS INC Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
ALX ONCOLOGY HOLDINGS INC (ALXO) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $163.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2026-05-08
- 2026-03-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $163.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $967.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $967.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $967.00K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four |
|---|---|
| 2026-03-31 | $163.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $967.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $967.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $967.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $967.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $939.00K 10-K · filed 2025-03-06 |
| 2024-09-30 | $939.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $939.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $939.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $912.00K 10-K · filed 2024-03-07 |
| 2023-09-30 | $912.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $912.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $912.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.19M 10-K · filed 2023-03-09 |
| 2022-09-30 | $1.19M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.19M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $939.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $446.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $446.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $446.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |